Philadelphia · Life Sciences

Philadelphia Biotech Recruiters — Cell & Gene Therapy Capital of the U.S.

Philadelphia is the U.S. capital of cell and gene therapy, anchored by Penn Medicine, CHOP, and a dense ecosystem of CGT biotechs spun out of academic medicine. Recruits Lab places scientists, clinical operations leaders, and CGT manufacturing talent across the region.

Schedule a Philadelphia Search Consultation Request Philadelphia Talent

Philadelphia Hiring Market Overview

Greater Philadelphia hosts the highest concentration of approved cell and gene therapy commercial programs in the U.S. The cluster includes Spark Therapeutics (Roche), Iovance, Century Therapeutics, Carisma, Cabaletta Bio, Passage Bio, and a deep tail of academic spin-outs from UPenn, CHOP, and Wistar.

CGT manufacturing is the bottleneck function. Vector production, autologous and allogeneic process development, GMP manufacturing, and CMC regulatory talent are in structural shortage. Most CGT manufacturing roles are 5 days on-site.

Compensation tracks Boston/SD for scientific roles and runs slightly above for CGT-specialized manufacturing talent.

Top Philadelphia Life Sciences Employers We Source From

Spark Therapeutics (Roche)IovanceCentury TherapeuticsCarismaCabaletta BioPassage BioTmunity (Kite/Gilead legacy)AdaptimmunePenn Medicine Center for Cellular ImmunotherapiesCHOP Center for Cellular & Molecular TherapeuticsWistar Institute spin-outs

Philadelphia Hiring Challenges

CGT Manufacturing Shortage

Vector production, autologous PD, and GMP manufacturing talent are in active shortage. Hiring without active sourcing is impossible.

Academic-to-Industry Translation

UPenn and CHOP spin-outs frequently underestimate industrial CGT process discipline. We calibrate on translational fit before the loop.

Regulatory Specificity

CGT CMC regulatory talent is a separate pool from small molecule and biologics. We screen accordingly.

Commute Geography

Center City, University City, King of Prussia, and the I-95 corridor are distinct submarkets. We pre-screen commute realism.

Philadelphia Life Sciences Salary Insights — 2026

Directional 2026 base salary estimates for venture-backed and mid-cap companies in this market. Excludes equity, bonus, and sign-on. Confirm against current market data before extending offers.

Role	Base Range	Notes
Senior Scientist, CGT	$160K–$215K
Principal Scientist, Vector PD	$215K–$285K
Director, CGT Manufacturing	$250K–$335K
Director, Clinical Operations (CGT)	$240K–$320K
VP, CMC (CGT)	$340K–$460K

Sources: blended Radford, Mercer, and Recruits Lab placement data 2026. Directional only.

Hiring Timeline in Philadelphia

Industry average is 100-120 days for a Director-level CGT search. Recruits Lab averages 18-30 days.

Related Recruiter Pages

Related Salary Guides

Broader Philadelphia Recruiting

This page focuses on life sciences hiring in Philadelphia. For broader Philadelphia recruiting coverage across AI, life sciences, SaaS, sales, and executive search, see our parent market page.

Philadelphia Recruiters

FAQ — Philadelphia Life Sciences Recruiting

Is Philadelphia the cell and gene therapy capital?

Yes. Greater Philadelphia hosts the highest concentration of approved CGT commercial programs in the U.S., anchored by Penn Medicine's Center for Cellular Immunotherapies, CHOP, Spark Therapeutics (Roche), Iovance, Century, Carisma, Cabaletta, and Passage Bio.

What is the salary for a CGT manufacturing director in Philadelphia?

Directors of CGT Manufacturing in Philadelphia earn $250K-$335K base in 2026, with VPs of CMC reaching $340K-$460K. Vector production and process development talent commands a 10-15% premium over comparable biologics roles.

How long does it take to hire CGT manufacturing talent in Philadelphia?

Industry average is 120+ days due to structural pool scarcity. Recruits Lab averages 18-30 days by maintaining a live map of vector PD, autologous, and allogeneic GMP talent across the region.